BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatment

Niederer, Fabienne; Scherer, Almut; Kyburz, Diego; Michel, Beat A.; Ciurea, Adrian

doi:10.1016/j.jbspin.2012.10.004

Cited by 3 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Работ, посвященных изучению воздействия терапии в целом и отдельных групп препаратов на концентрацию BAFF и APRIL, крайне мало. Введение внутривенного иммуноглобулина пациентам с хронической воспалительной демиелинизирующей полинейропатией снижает продукцию BAFF моноцитами [48], стимулирующее действие в мышиных моделях оказывают эстрогены и интерферон α [49], на фоне терапии ингибиторами ФНОα через 3 мес повышается исходно низкий уро-вень BAFF у больных АС [39]. T. Vallerskog и соавт.…”

Section: Discussionunclassified

Clinical Value of Baff and April Concentrations in Systemic Lupus Erythematosus

Panafidina¹,

Сохова²,

Попкова³

et al. 2016

rsp

View full text Add to dashboard Cite

Section: Discussionunclassified

Clinical Value of Baff and April Concentrations in Systemic Lupus Erythematosus

Panafidina¹,

Сохова²,

Попкова³

et al. 2016

rsp

View full text Add to dashboard Cite

Cupping therapy for treating ankylosing spondylitis: The evidence from systematic review and meta-analysis

Wang

Zheng

2018

Complementary Therapies in Clinical Practice

View full text Add to dashboard Cite

Baguan Therapy Is an Alternative in Treating Ankylosing Spondylitis: A Systematic Review Based on Existing Randomized Controlled Trials

Wang¹,

Tian²,

Lv³

et al. 2019

Complement Med Res

View full text Add to dashboard Cite

Background: The aim of this systematic review was to evaluate the evidence available on the effects of Baguan therapy for ankylosing spondylitis (AS) patients. Materials and Methods: The following databases were searched from their inception to August 2018: PubMed, Web of Science, AMED, Cochrane Library, Google, EMBASE, the China National Knowledge Infrastructure databases, Wanfang Data, CiNii, KoreaMed, and the Iranian Registry of Clinical Trials. Randomized controlled trials (RCTs), which assessed the effects of Baguan therapy for AS, were included in our review. The methodological quality of eligible studies was assessed by the Cochrane Collaboration’s tool. The RevMan 5.3 software was used for quantitative analysis of RCTs. Heterogeneity was assessed using I² statistics. Results: Four studies were included in our review. The aggregated results indicated that Baguan therapy improved the treatment effect (risk ratio 1.21, 95% CI 1.10–1.34, p < 0.01) as well as physical function (Bath Ankylosing Spondylitis Functional Index) (mean difference –1.56, 95% CI –2.01 to –1.12, p < 0.01) and reduced disease activity (Bath Ankylosing Spondylitis Disease Activity Index) (mean difference –0.71, 95% CI –1.09 to –0.33, p < 0.01) in patients with AS. Conclusion: Due to the low quality of included trials, it is difficulty to draw the firm conclusion that Baguan therapy may have beneficial effects on AS.

show abstract

BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatment

Cited by 3 publications

References 8 publications

Clinical Value of Baff and April Concentrations in Systemic Lupus Erythematosus

Clinical Value of Baff and April Concentrations in Systemic Lupus Erythematosus

Cupping therapy for treating ankylosing spondylitis: The evidence from systematic review and meta-analysis

Baguan Therapy Is an Alternative in Treating Ankylosing Spondylitis: A Systematic Review Based on Existing Randomized Controlled Trials

Contact Info

Product

Resources

About